Nuclear Reprogramming Using miRNA to Boost iPS Cell Yield
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for preparing induced pluripotent stem cells through nuclear reprogramming are inefficient, particularly when excluding c-Myc, and existing technologies do not effectively utilize microRNAs to enhance reprogramming efficiency.
Innovation Solution
The use of specific microRNAs, such as those in the hsa-miR-302-367 cluster, in combination with nuclear reprogramming factors like Oct3/4 and Klf4, to enhance the efficiency of nuclear reprogramming without the need for c-Myc and Sox2, by introducing these miRNAs and factors into somatic cells using viral vectors.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If nuclear reprogramming is carried out using three factors (Oct3/4, Sox2, Klf4) excluding c-Myc, then the production efficiency of induced pluripotent stem cells becomes low, but this approach avoids tumorigenic risks associated with c-Myc
Solution Approach 1:
The patent introduces miRNAs as intermediary molecules that mediate between the reprogramming factors and the target genes. These miRNAs enhance the reprogramming efficiency by regulating gene expression, allowing the three-factor combination (Oct3/4, Sox2, Klf4) to achieve high efficiency without requiring c-Myc, thus resolving the contradiction between safety and productivity
Solution Approach 2:
The patent changes the parameter of reprogramming efficiency by introducing miRNAs that regulate gene expression. This parameter change allows the system to achieve high efficiency with three factors instead of four, modifying the efficiency parameter without adding the harmful c-Myc factor
2Ease of manufacture
If viral vectors are used to introduce nuclear reprogramming factors into somatic cells, then the reprogramming process can be achieved, but the efficiency remains low without miRNA assistance
Solution Approach 1:
The patent merges the viral vector delivery system with miRNA expression to create a combined reprogramming system. The viral vectors simultaneously deliver both the nuclear reprogramming factors and the miRNAs, synergistically enhancing reprogramming efficiency while maintaining the feasibility of the process
Data Source
AI summary
This relates to a method of preparing induced pluripotent stem cells, comprising a nuclear reprogramming step with a nuclear reprogramming factor in the presence of miRNA, wherein said miRNA has a property of providing a higher nuclear reprogramming efficiency in the presence of said miRNA than in the absence thereof.